In conclusion, these data suggest that NFAT factors play a significant role in RCC cell scattering and migration through CD40 crosslinking and could represent a potential therapeutic target in the setting of patients with metastatic RCC. The gene discussed is CD40; the disease is renal cell carcinoma.